<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3F2881FA-E476-4F47-8701-DF07A4EBCE5B"><gtr:id>3F2881FA-E476-4F47-8701-DF07A4EBCE5B</gtr:id><gtr:name>Gamlen Tableting Limited</gtr:name><gtr:address><gtr:line1>BIOCITY NOTTINGHAM , PENNYFOOT STREET</gtr:line1><gtr:city>NOTTINGHAM</gtr:city><gtr:postCode>NG1 1GF</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3F2881FA-E476-4F47-8701-DF07A4EBCE5B" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3F2881FA-E476-4F47-8701-DF07A4EBCE5B</gtr:id><gtr:name>Gamlen Tableting Limited</gtr:name><gtr:address><gtr:line1>BIOCITY NOTTINGHAM , PENNYFOOT STREET</gtr:line1><gtr:city>NOTTINGHAM</gtr:city><gtr:postCode>NG1 1GF</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>100492.0</gtr:offerGrant><gtr:projectCost>223316.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C2C7536C-4A5B-4564-8DA8-FA18C13B6C29"><gtr:id>C2C7536C-4A5B-4564-8DA8-FA18C13B6C29</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Gamlen</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=720394"><gtr:id>3E2883DB-F095-4387-8FAC-C61BB8C3C4F6</gtr:id><gtr:title>Gamlen Tableting Ltd: Low cost, instrumented force- and displacementcontrolled tableting press for replication of full-scale production pharmaceutical tablets from a laboratory-scale device</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>GRD Development of Prototype</gtr:grantCategory><gtr:grantReference>720394</gtr:grantReference><gtr:abstractText>Gamlen Tabletting (GT) is an SME, established in 2012 to develop an accurate, easy to use,
small scale, low cost, instrumented tableting machine for the pharmaceutical industry and
academia. The launch product, a 500kg load Gamlen Tablet Press (GTP) has been in the
market for a year, and has been independently verified by GSK as manufacturing tablets
which accurately replicate the characteristics of those from full-scale production machinery.
The 500kg GTP has found use in pre-formulation studies, formulation development, process
control, QC testing, teaching and R&amp;amp;D, where it has found widespread acceptance.
Feedback from current and potential users indicates the need for higher compaction loads (to
enable the compression of a wider range of powders) plus additional instrumentation to better
assess powder characteristics. The 500kg GTP already operating at industry-leading
tolerances; developing a larger, higher capacity machine while maintaining accuracy poses
significant technical challenges to GT in terms of both construction and control.
GT proposes a 15 month project to develop and demonstrate a prototype enhanced GTP.
Work will focus on:
? Machine improvements: to increase the load rating of the machine to more accurately
replicate full-scale production processing conditions;
? Bolt-on additional functionality: tablet ejection force measurement and tablet labelling
modules;
? Compression curve analysis: to enable the study material properties during the compression
event. This will further extent utility and increase market potential;
? Developing standardised powder compressibility tests: this will allow users to easily identify
powders that will make high quality tablets.
GT will maximise value for money by conducting aspects of the work in-house, while
subcontracting tasks that are outside of current capability.</gtr:abstractText><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2014-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>100492</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">720394</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>